Metabolics Diabetes New Onset
Showing 1 - 25 of >10,000
Diabetes, Type 1 Diabetes, Diabetes type1 Trial in Charlestown (Bacillus Calmette-Guérin, Saline Injection)
Recruiting
- Diabetes Mellitus
- +3 more
- Bacillus Calmette-Guérin
- Saline Injection
-
Charlestown, MassachusettsImmunobiology Labs CNY 149
May 10, 2023
Diabetes, Type 1 Trial in Stockholm (TCD601, Placebo)
Recruiting
- Diabetes Mellitus, Type 1
- TCD601
- Placebo
-
Stockholm, Huddinge, SwedenKarolinska University Hosptial
Sep 1, 2023
Type 2 Diabetes Trial (GMRx4 polypill - sitagliptin, dapagliflozin, metformin, Metformin)
Not yet recruiting
- Type 2 Diabetes
- GMRx4 polypill - sitagliptin, dapagliflozin, metformin
- Metformin
- (no location specified)
Apr 27, 2023
Individuals With New-Onset Diabetes Mellitus
Recruiting
- Pancreatic Cancer
- Pancreatic Neoplasms
- MRI/MRCP
-
New Haven, Connecticut
- +1 more
Jan 19, 2023
Diabetes, Pre Diabetes, ASCVD Trial (high-intensity statin arm, low-intensity statin plus ezetimibe)
Not yet recruiting
- Diabetes Mellitus
- +2 more
- high-intensity statin arm
- low-intensity statin plus ezetimibe
- (no location specified)
Oct 12, 2022
"Effect of Screening Using Imaging on Early Detection of PDAC in
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma (PDAC)
- A blood sample for CA 19-9 (cancer detection test)
- (no location specified)
Sep 13, 2023
Diabetes, Type 1 Trial in Milan (Human pancreatic islet, ATG, Pegylated G-CSF)
Active, not recruiting
- Diabetes Mellitus, Type 1
- Human pancreatic islet
- +3 more
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Dec 1, 2022
Type 1 Diabetes Trial in MIlan (Probiotic Vivomixx®, Placebo)
Recruiting
- Type 1 Diabetes
- Probiotic Vivomixx®
- Placebo
-
MIlan, ItalyAutoimmune Pathogenesis Unit
Mar 10, 2023
Pancreatic Cancer Trial (MRI/Imaging)
Not yet recruiting
- Pancreatic Cancer
- MRI/Imaging
- (no location specified)
Jul 1, 2022
Type1 Diabetes Trial in United States (HCL, verapamil 120mg tablet, non-HCL)
Completed
- Type1 Diabetes
- HCL
- +3 more
-
Palo Alto, California
- +5 more
Oct 31, 2022
Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)
Not yet recruiting
- Diabetes Mellitus, Type 1
- Abrocitinib 200 MG Oral Tablet
- +2 more
- (no location specified)
Feb 21, 2023
Diabetes Trial in Xi'an (UDCA)
Recruiting
- Diabetes Mellitus
-
Xi'an, Shanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Aug 11, 2022
Peri-operative Period in Kidney Transplant Recipients
Recruiting
- New Onset Diabetes After Transplantation
- continuous glucose monitoring
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 22, 2023
Type 1 Diabetes, type1diabetes, Type 1 Diabetes Trial in Milwaukee (Lactiplantibacillus plantarum, Placebo)
Recruiting
- Type 1 Diabetes
- +2 more
- Lactiplantibacillus plantarum
- Placebo
-
Milwaukee, WisconsinMedical College of Wisconsin
Apr 8, 2022
Type 1 Diabetes Trial (Gluten Free Diet, Placebo)
Terminated
- Type 1 Diabetes Mellitus
- Gluten Free Diet
- Placebo
- (no location specified)
Oct 31, 2022
Type 1 Diabetes Trial in North Adelaide, Fitzroy, Parkville (Baricitinib, Placebo)
Active, not recruiting
- Type 1 Diabetes
- Baricitinib
- Placebo
-
North Adelaide, South Australia, Australia
- +3 more
May 4, 2022
Hyperglycemia, Diabetes, Pancreas Ductal Adenocarcinoma Trial in Pasadena, Houston (Enriching New-onset Diabetes for Pancreatic
Recruiting
- Hyperglycemia
- +2 more
- Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC) score
- Abdominal imaging
-
Pasadena, California
- +1 more
Mar 29, 2022
Diabetes Trial in San Antonio (metformin\pioglitazone\exenatide, metformin, glyburide and glargine)
Active, not recruiting
- Diabetes
- metformin\pioglitazone\exenatide
- metformin, glyburide and glargine
-
San Antonio, TexasTexas Diabetes Institute
Mar 8, 2022
Post-transplant Diabetes, New Onset Diabetes After Transplant, New Onset Diabetes After Transplantation Trial in London
Completed
- Post-transplant Diabetes Mellitus
- +6 more
- Metformin
- Placebo
-
London, United KingdomRoyal London Hospital, Barts Health NHS Trust
Oct 17, 2022
Covid19, type1diabetes Trial in Esbjerg
Recruiting
- Covid19
- type1diabetes
-
Esbjerg, DenmarkHospital of South West Jutland
Mar 16, 2022
Type 2 Diabetes, Impaired Glucose Tolerance, Non-Alcoholic Fatty Liver Disease Trial (Semaglutide Pen Injector, Placebo)
Not yet recruiting
- Type 2 Diabetes Mellitus
- +3 more
- Semaglutide Pen Injector
- Placebo
- (no location specified)
Jul 27, 2022
Pancreatic Cancer Trial in San Diego (Early detection pancreatic cancer test, Early detection pancreatic cancer test and MRI
Not yet recruiting
- Pancreatic Cancer
- Early detection pancreatic cancer test
- Early detection pancreatic cancer test and MRI Imaging
-
San Diego, CaliforniaBluestar Genomics, Inc.
Dec 27, 2021
Disorder Related to Renal Transplantation, Diabetes Trial in Besançon (Vildagliptin, Placebo)
Recruiting
- Disorder Related to Renal Transplantation
- Diabetes
- Vildagliptin
- Placebo
-
Besançon, FranceCHU de Besançon
Aug 1, 2022
Patients With and Without Diabetes After New Onset of STEMI
Recruiting
- ST Elevation Myocardial Infarction
- Diabetes Mellitus
-
Düsseldorf, North-Rhine Westphalia, GermanyGerman Diabetes Center
Sep 7, 2021
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
Active, not recruiting
- IGT - Impaired Glucose Tolerance
- T2D
- Oral Glucose Tolerance Test
- +3 more
-
New Haven, ConnecticutYale University
Feb 8, 2022